Takeda Canada Inc.

Jan 29, 2025

Héma-Québec to Reimburse HyQvia® for the Treatment of Immunodeficiencies in Adult and Pediatric Patients Over 2 Years of Age

Jan 21, 2025

Takeda Recognized as a Top Employer in Canada for Third Consecutive Year

Aug 22, 2024

Takeda Releases New Report to Support Health System Readiness for Rare Diseases in Canada

Jun 21, 2024

Takeda's HyQvia® Approved as Replacement Therapy for Primary Humoral Immunodeficiency and Secondary Humoral Immunodeficiency in Pediatric Patients 2 years of Age and Older

Feb 26, 2024

Championing Rare Voices on Rare Disease Day